Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening (Q46079813)
Jump to navigation
Jump to search
scientific article published on 15 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening |
scientific article published on 15 February 2009 |
Statements
1 reference
Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening (English)
1 reference
Gregory J Dore
1 reference
Monica C Robotin
1 reference
Melanie Kansil
1 reference
Kirsten Howard
1 reference
Jacob George
1 reference
Steven Tipper
1 reference
Miriam Levy
1 reference
Andrew G Penman
1 reference
15 February 2009
1 reference
1 reference
50
1 reference
5
1 reference
990-998
1 reference
Identifiers
1 reference